Associated Papers
Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap.
Gu J et al.
Nature Biotechnology, 2025
CRISPRmap: Sequencing-free optical pooled screens mapping multi-omic phenotypes in cells and tissue.
Gu J et al.
Biorxiv : the Preprint Server for Biology, 2023
38234835 (PubMed )
Supplement: media-5.xlsx › ClinVar_update_Dec2023
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants.
Zaremba A et al.
Pigment Cell & Melanoma Research, 2022
BARD1 mystery: tumor suppressors are cancer susceptibility genes.
Hawsawi YM et al.
Bmc Cancer, 2022
Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives.
Abdel-Razeq H et al.
Frontiers in Oncology, 2022
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Fanale D et al.
Cancers, 2020
Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.
Alenezi WM et al.
Genes, 2020
Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
Adamovich AI et al.
Plos Genetics, 2019
Identification of functional SNPs in BARD1 gene and in silico analysis of damaging SNPs: based on data procured from dbSNP database.
Alshatwi AA et al.
Plos One, 2012
BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.
Gorringe KL et al.
Breast Cancer Research and Treatment, 2008
Select a paper to view details